Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

PURPOSE: The hu14.18-IL2 fusion protein consists of interleukin-2 molecularly linked to a humanized monoclonal antibody that recognizes the GD2 disialoganglioside expressed on neuroblastoma cells. This phase II study assessed the antitumor activity of hu14.18-IL2 in two strata of patients with recur...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Shusterman, Suzanne, London, Wendy B., Gillies, Stephen D., Hank, Jacquelyn A., Voss, Stephan D., Seeger, Robert C., Reynolds, C. Patrick, Kimball, Jennifer, Albertini, Mark R., Wagner, Barrett, Gan, Jacek, Eickhoff, Jens, DeSantes, Kenneth B., Cohn, Susan L., Hecht, Toby, Gadbaw, Brian, Reisfeld, Ralph A., Maris, John M., Sondel, Paul M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2010
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020698/
https://ncbi.nlm.nih.gov/pubmed/20921469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.8861
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items